DE69314186D1 - Brausemischungen enthaltend ibuprofen und verfahren - Google Patents

Brausemischungen enthaltend ibuprofen und verfahren

Info

Publication number
DE69314186D1
DE69314186D1 DE69314186T DE69314186T DE69314186D1 DE 69314186 D1 DE69314186 D1 DE 69314186D1 DE 69314186 T DE69314186 T DE 69314186T DE 69314186 T DE69314186 T DE 69314186T DE 69314186 D1 DE69314186 D1 DE 69314186D1
Authority
DE
Germany
Prior art keywords
pharmaceutically acceptable
ibuprofen
brewing
mixtures containing
sufficient amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69314186T
Other languages
English (en)
Other versions
DE69314186T2 (de
Inventor
Nicole Bru-Magniez
Jean-Francois Cordoliani
Gerard Thauvin
Jehan-Yves Drouin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNION PHARMA SCIENT APPL
UPSA SAS
Original Assignee
UNION PHARMA SCIENT APPL
UPSA SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9436398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69314186(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by UNION PHARMA SCIENT APPL, UPSA SAS filed Critical UNION PHARMA SCIENT APPL
Publication of DE69314186D1 publication Critical patent/DE69314186D1/de
Application granted granted Critical
Publication of DE69314186T2 publication Critical patent/DE69314186T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69314186T 1992-12-09 1993-12-09 Brausemischungen enthaltend ibuprofen und verfahren Revoked DE69314186T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9214851A FR2698788B1 (fr) 1992-12-09 1992-12-09 Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
PCT/FR1993/001216 WO1994013279A1 (fr) 1992-12-09 1993-12-09 Composition pharmaceutique effervescente contenant de l'ibuprofene et son procede de preparation

Publications (2)

Publication Number Publication Date
DE69314186D1 true DE69314186D1 (de) 1997-10-30
DE69314186T2 DE69314186T2 (de) 1998-02-12

Family

ID=9436398

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69314186T Revoked DE69314186T2 (de) 1992-12-09 1993-12-09 Brausemischungen enthaltend ibuprofen und verfahren

Country Status (26)

Country Link
US (2) US5480652A (de)
EP (1) EP0673245B1 (de)
JP (1) JP3579421B2 (de)
KR (1) KR950702414A (de)
AT (1) ATE158504T1 (de)
AU (1) AU679200B2 (de)
CA (1) CA2150945C (de)
CZ (1) CZ289304B6 (de)
DE (1) DE69314186T2 (de)
DK (1) DK0673245T3 (de)
EE (1) EE03089B1 (de)
ES (1) ES2110212T3 (de)
FI (1) FI111517B (de)
FR (1) FR2698788B1 (de)
GE (1) GEP19991686B (de)
GR (1) GR3025634T3 (de)
HU (1) HU220632B1 (de)
LV (1) LV11984B (de)
MD (1) MD872G2 (de)
NZ (1) NZ258596A (de)
RU (1) RU2134577C1 (de)
SK (1) SK281775B6 (de)
TJ (1) TJ253B (de)
TW (1) TW280774B (de)
UA (1) UA27058C2 (de)
WO (1) WO1994013279A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19502789A1 (de) * 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
DE19606151C2 (de) 1996-02-20 1999-05-12 Losan Pharma Gmbh Ibuprofen-Brausezubereitung sowie Verfahren zur Herstellung derselben
US6534016B1 (en) 1997-04-30 2003-03-18 Richmond Cohen Additive preparation and method of use thereof
US6225123B1 (en) 1997-04-30 2001-05-01 Becton Dickinson And Company Additive preparation and method of use thereof
GB9721397D0 (en) * 1997-10-09 1997-12-10 Verdugt Bv Anticaking agents
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
DE19814257A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
DE19962251A1 (de) * 1999-12-22 2001-09-06 Hermes Fabrik Pharm Praeparate Lutschtablette
JP2004506609A (ja) * 2000-05-26 2004-03-04 ノボ　ノルディスク　アクティーゼルスカブ 新たなる医薬組成物及びその調製の為の方法
AU2000249111A1 (en) * 2000-05-30 2001-12-11 Dr. Reddy's Research Foundation New pharmaceutical composition and the process for its preparation
AR029538A1 (es) * 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos
US7488496B2 (en) * 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
AU2003219999A1 (en) 2002-03-06 2003-09-22 Lifizz, Inc. Effervescent compositions comprising bisphosphonates and methods related thereto
DE102006029233A1 (de) * 2006-06-26 2007-12-27 Liedtke, Rainer K., Dr. Formulierungen zur Verbesserung der Verträglichkeit nichtsteroidaler Antiphlogistika
EP1902708A1 (de) * 2006-09-25 2008-03-26 Losan Pharma GmbH Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
US8445545B2 (en) * 2008-05-07 2013-05-21 Nicholas DeSica Pharmaceutical composition, method of preparation and methods of treating aches/pains
US9267112B2 (en) 2011-05-10 2016-02-23 The Regents Of The University Of California Adenovirus isolated from Titi Monkeys
US10221218B2 (en) 2011-05-10 2019-03-05 The Regents Of The University Of California Adenovirus isolated from titi monkeys
WO2013116112A1 (en) 2012-02-01 2013-08-08 Kraft Foods Global Brands Llc Low calorie drink tablet
JP5877778B2 (ja) * 2012-05-28 2016-03-08 株式会社ホットアルバム炭酸泉タブレット 錠剤の製造方法及び錠剤
RU2519099C1 (ru) * 2012-11-08 2014-06-10 Федеральное государственное бюджетное учреждение науки Ордена Трудового Красного Знамени Институт нефтехимического синтеза им. А.В. Топчиева Российской академии наук (ИНХС РАН) Фармацевтическая композиция
FR3060391A1 (fr) * 2016-12-20 2018-06-22 Promindus Sarl Composition pharmaceutique anti douleur

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
CH677606A5 (de) * 1988-07-12 1991-06-14 Aesculapius Pharma Sa
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles

Also Published As

Publication number Publication date
CZ289304B6 (cs) 2001-12-12
FR2698788B1 (fr) 1995-03-03
JPH08504427A (ja) 1996-05-14
EP0673245B1 (de) 1997-09-24
TW280774B (de) 1996-07-11
SK281775B6 (sk) 2001-07-10
FI111517B (fi) 2003-08-15
ES2110212T3 (es) 1998-02-01
SK72895A3 (en) 1995-11-08
HUT73249A (en) 1996-07-29
RU2134577C1 (ru) 1999-08-20
HU9501671D0 (en) 1995-08-28
LV11984A (lv) 1998-03-20
MD872G2 (ro) 1998-08-31
MD872F1 (en) 1997-11-30
FI945452A0 (fi) 1994-11-21
WO1994013279A1 (fr) 1994-06-23
AU5653694A (en) 1994-07-04
CA2150945C (fr) 2006-11-28
UA27058C2 (uk) 2000-02-28
EP0673245A1 (de) 1995-09-27
FI945452A (fi) 1995-06-07
FR2698788A1 (fr) 1994-06-10
ATE158504T1 (de) 1997-10-15
US5567437A (en) 1996-10-22
US5480652A (en) 1996-01-02
DK0673245T3 (da) 1998-04-27
EE03089B1 (et) 1998-06-15
GR3025634T3 (en) 1998-03-31
CZ141995A3 (en) 1995-10-18
KR950702414A (ko) 1995-07-29
LV11984B (lv) 1998-05-20
HU220632B1 (hu) 2002-03-28
DE69314186T2 (de) 1998-02-12
TJ253B (en) 2000-05-12
AU679200B2 (en) 1997-06-26
JP3579421B2 (ja) 2004-10-20
GEP19991686B (en) 1999-08-05
CA2150945A1 (fr) 1994-06-23
NZ258596A (en) 1997-01-29

Similar Documents

Publication Publication Date Title
DE69314186D1 (de) Brausemischungen enthaltend ibuprofen und verfahren
IL74707A0 (en) Anti-viral compositions comprising pyridazinamines,certain such novel compounds and their preparation
HUT49629A (en) Process for producing peptide-boronic acid derivatives inhibiting trypsin-like proteases and pharmaceutical compositions comprising such compounds as active ingredient
HUT64065A (en) Process for producing quinolone- and naphthyridonecarboxylic acid derivatives and pharmaceutical compositions comprising same as active ingredient
HUT60466A (en) Process for producing amino acid derivatives and pharmaceutical compositions comprising such active ingredient
HUT51254A (en) Process for producing amino acid derivatives and pharmaceutical compositions comprising same as active ingredient
ZA955547B (en) Multiple unit pharmaceutical preparation
IL107221A0 (en) Carboxylic acid derivatives, pharmaceutical compositions containing them and processes for their preparation
EP0221041A3 (de) Benzimidazolderivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
PT86186A (en) Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same
HU9400430D0 (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
MY129946A (en) Compound with gastric acid inhibitory effect and process for its preparation.
UA40636C2 (uk) Фармацевтична композиція для одержання стабільного порошку, яка містить як активний компонент асоціацію ацетилсаліцилової кислоти та метоклопраміду, фармацевтичний препарат у формі порошку та спосіб одержання цього препарату
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
HUT61740A (en) Process for producing 2-piperidinyl-pyrimidine-4-carboxamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT53121A (en) Process for producing amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
IE43848L (en) Pharmaceutical compositions
HUT63381A (en) Process for producing new phenylsulfonylacrylate derivatives and pharmaceutical compositions comprising same as active ingredient
MY102368A (en) Solid sustained-release composition
MX9705592A (es) Composiciones farmaceuticas que contienen corticosteroides y preparacion de las mismas.
JO1664B1 (en) The compound has the effect of immobilizing gastric acid and the process of preparing it

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation